Category | Issue | N of studies | Measures taken or recommended | Impact on study or clinical application* |
---|---|---|---|---|
Data acquisition | ||||
TCD | Anomalous/contaminated data (e.g., movement, electrocautery, physiologically impossible velocity) | 7 | Manual removable of artifacts, utilize only unilateral recordings, or patient exclusion | In cardiac surgery, this affects pre/post-CPB periods more due to high electrocautery activity. Patient attrition and signal loss related to this cause were up to 23% [51] and 36% respectively [60]. In brain injury, attrition rate related to this cause was 7% [33]. Manual removal might not perfectly rule out contaminated signals. [52, 56, 57, 62] |
Lack of transcranial window | 4 | Patient exclusion | Minimally impacts recruitment rate (4–7% of recruited patients) and could be identified early in the research | |
Forehead obstruction (e.g., monitors, dressing, hemicraniectomy) | 1 | Patient exclusion or use only unilateral recordings | Specific prevalence was not reported [33] | |
NIRS | Contaminated signals (metabolic/physiological changes incompatible with the recording mechanism) | 2 | Patient exclusion | Patient attrition related to this cause was few (6%)[53]; could be inherent to the technology thereby impact is masked, specific populations might be more affected and should be identified [44] 5/6/2025 7:19:00 PM |
Sensor adhesion issues | 1 | Remove recordings | Specific prevalence was not reported [39] | |
Optode malfunction | 1 | Patient exclusion or use only unilateral recordings | Affected 1% of patients [38] | |
Recording failure | 1 | Specific prevalence was not reported [37] | ||
Equipment unavailability | 1 | Specific prevalence was not reported [40] | ||
MAP | Anomalous or contaminated data | 3 | Manual or auto/algorithmic MAP cleaning | |
Software failure (loss of continuous MAP data) | 1 | Patient exclusion and data cleaning | Affected up to 23% participants [62] | |
Other or unspecified | Equipment unavailability, no high-fidelity recording, data loss while transferring, or protocol miscommunication | 4 | Patient exclusion, re-training and equipping sites, extract data immediately after recording, review protocol and improve documentation | Affected 3% to 53% of eligible participants depending on when the protocol is reviewed and revised [37, 40, 43, 48] |
Anomalous or contaminated data | 3 | Data cleaning or patient exclusion | Affected 14% of data recorded [37] and 23–26% of participants [55, 58] | |
Damaged recordings or other recording complications | 2 | Patient exclusion | ||
ICU discharge before study completion | 1 | Modify study design/timing | Specific prevalence was not reported [48] | |
Target calculation | ||||
 | No observable MAP limits—MAP always above/outside acceptable thresholds | 15 | Define LLA as the lowest COx above the threshold, adjusting threshold values | Affected 2–100% participants depending on study methods. Gergelé et al.[52] tried calculating LLA with 15-min long recording and was unsuccessful. Møller et al.[35] tried calculating LLA in patients with bacterial meningitis in the first 24 h after diagnostic lumbar puncture and was also unsuccessful until later in their recovery. Asides from these two studies, loss related to this cause is lower than 35%. Yield appears lower for ULA vs LLA [29]. [33, 43,44,45, 49, 51, 53, 54, 63, 65,66,67] |
No observable MAP limits—MAP always below/within acceptable thresholds | 7 | No steps needed as assumed part of healthy variation; prevalence should be transparently reported | Affected 2–60% of participants, regression studies more heavily affected; threshold values influenced detection rates; surgical studies generally had better identification rates than ICU studies (2–18% loss versus 26–27% [correlation approach only]) [29, 43, 49, 53, 54, 63, 67] | |
Short recording duration | 5 | Attempts made to calculate but if unsuccessful patients will be excluded | ||
Fluctuating thresholds | 1 | N/A | Affected 15% (Mx2s) and 16% (Mx10s) of participants [51] |